Evidence map›Paper›PMID 31132458›Full record

ArticleBrain, behavior, and immunity2019

C/EBPβ regulates the M2 transcriptome in β-adrenergic-stimulated macrophages.

Donald M Lamkin, Shreyesi Srivastava, Karen P Bradshaw, Jenna E Betz, Kevin B Muy, Anna M Wiese, Shelby K Yee, Rebecca M Waggoner, Jesusa M G Arevalo, Alexander J Yoon and 3 more

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Human mutation · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALS.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 2 countries.

Donald M LamkinNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States; Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles 90095, United States; Jonsson Comprehensive Cancer Center, University of California, Los Angeles 90095, United States. Electronic address: dlamkin@ucla.edu.
Shreyesi SrivastavaNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Karen P BradshawNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Jenna E BetzNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Kevin B MuyNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Anna M WieseNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Shelby K YeeNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Rebecca M WaggonerNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Jesusa M G ArevaloNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States; Divison of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles 90095, United States.
Alexander J YoonPasarow Mass Spectrometry Laboratory, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Kym F FaullDepartment of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles 90095, United States; Pasarow Mass Spectrometry Laboratory, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States.
Erica K SloanNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States; Jonsson Comprehensive Cancer Center, University of California, Los Angeles 90095, United States; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Melbourne, VIC 3002, Australia.
Steve W ColeNorman Cousins Center for PNI, Semel Institute for Neuroscience, University of California, Los Angeles 90095, United States; Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles 90095, United States; Jonsson Comprehensive Cancer Center, University of California, Los Angeles 90095, United States; Divison of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles 90095, United States.
University of California, Los Angeles · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JAMIESON-KARAVODIN, BETH DEIRDRE · 1991 to 2018
$39.9M
Social regulation of pro-inflammatory monocytesR01AG043404 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COLE, STEVE W · 2014 to 2018
$1.6M
Translational Research of Biobehavioral Mechanisms in Cancer ControlK07CA188237 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LAMKIN, DONALD MICHAEL · 2015 to 2019
$766k
NCI NIH HHS K07 CA188237NCI NIH HHS P30 CA016042NIAID NIH HHS P30 AI028697NIA NIH HHS R01 AG043404
6 · The paper itself

Abstract

At the M2 terminal of the macrophage activation spectrum, expression of genes is regulated by transcription factors that include STAT6, CREB, and C/EBPβ. Signaling through β-adrenergic receptors drives M2 activation of macrophages, but little is known about the transcription factors involved. In the present study, we found that C/EBPβ regulates the signaling pathway between β-adrenergic stimulation and expression of Arg1 and several other specific genes in the greater M2 transcriptome. β-adrenergic signaling induced Cebpb gene expression relatively early with a peak at 1 h post-stimulation, followed by peak Arg1 gene expression at 8 h. C/EBPβ transcription factor activity was elevated at the enhancer region for Arg 1 at both 4 and 8 h after stimulation but not near the more proximal promoter region. Knockdown of Cebpb suppressed the β-adrenergic-induced peak in Cebpb gene expression as well as subsequent accumulation of C/EBPβ protein in the nucleus, which resulted in suppression of β-adrenergic-induced Arg1 gene expression. Analysis of genome-wide transcriptional profiles identified 20 additional M2 genes that followed the same pattern of regulation by β-adrenergic- and C/EBPβ-signaling. Promoter-based bioinformatic analysis confirmed enrichment of binding motifs for C/EBPβ transcription factor across these M2 genes. These findings pinpoint a mechanism that may be targeted to redirect the deleterious influence of β-adrenergic signaling on macrophage involvement in M2-related diseases such as cancer.

Indexed as

Adrenergic AgentsAnimalsArginaseCCAAT-Enhancer-Binding Protein-betaFemaleGene Expression RegulationMacrophage ActivationMacrophagesMiceMice, Inbred BALB CPromoter Regions, GeneticRAW 264.7 CellsReceptors, Adrenergic, betaSignal TransductionTranscription FactorsTranscriptomeAdrenergic AgentsArg1 protein, mouseArginaseCCAAT-Enhancer-Binding Protein-betaReceptors, Adrenergic, betaTranscription FactorsAdrenergic receptorBioinformaticsFunctional genomicsMacrophageTranscription factorTumor immunology

Identifiers

PMID31132458
PMCPMC6660400
OpenAlexW2946048312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.